'Magic Pill' for Patients With Aggressive Prostate Cancer On the Anvil

by VR Sreeraman on  October 12, 2010 at 1:53 PM Drug News
RSS Email Print This Page Comment
A study from the Institute of Cancer Research based in London and Surrey indicates that a potentially life-prolonging pill for men with aggressive prostate cancer could be available within a year.
 'Magic Pill' for Patients With Aggressive Prostate Cancer On the Anvil
'Magic Pill' for Patients With Aggressive Prostate Cancer On the Anvil
Advertisement

The abiraterone acetate drug, for which phase three trials were halted on ethical grounds, will offer new hope to men with advanced prostate cancer.

Advertisement
The study has important implications because currently men with this aggressive type of prostate cancer currently have very few treatment options and a poor prognosis.

Risk of death was reduced by 35percent in men receiving abiraterone while survival was increased by 36 percent from a midpoint of 10.9 to 14.8 months.

"The news that abiraterone acetate may extend survival with manageable side-effects will be incredibly important to men with prostate cancer and their families," Sky News quoted study leader Dr Johan de Bono as saying.

Results from the trial have been presented at the European Society for Medical Oncology Congress in Milan, Italy.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Tattoos A Body Art Hematuria Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive